Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Apellis Pharmaceuticals (APLS) Q2 2023 Earnings
APLS
31
Jul
Confirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-1.75
-1.51
-1.26
-1.02
Details
Expected EPS
-1.32
Actual EPS
-1.02
Surprise EPS
0.3
Surprise Percent
+22.73%
Description
Apellis Pharmaceuticals (APLS) has reported earnings of -1.02 per share for Q2 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login